InsiderClue

Insider trading

Period: 120 months Stock: MDXG Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
When Periodin use
Who Role
The trade Type of tradein use Minimum amount Plan Share of their own holding
Ownership What the chief executive holds
When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

1 month 12 months 120 months
67 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

Anyone CEO CFO Other officers Directors 10% owners
67 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

Any71 Buys4 Sells67 Cluster buys
67 decisions over 120 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

Any $100K or more $1M or more $10M or more $100M or more $500M or more
67 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
Any Discretionary Scheduled (10b5-1) Not stated Not on a plan
67 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
67 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

67 decisions over 120 months
Stock
Insider
Type ?
Value ↓
Of own stake ↓
Why it stands out
MDXG MIMEDX GROUP, INC.
6 Nov 2025
Maersk-Moller Kimberly Chief Commercial Officer
Sold at will
$432.33K 58,300 at 7.42
19.7%
Not planned
MDXG MIMEDX GROUP, INC.
17 Mar 2025
Maersk-Moller Kimberly Chief Commercial Officer
Sold at will
$14.14K 1,759 at 8.04
0.6%
Not planned
MDXG MIMEDX GROUP, INC.
13 Mar 2025
Hulse William Frank IV General Counsel and CAO
Sold at will 2×
$430.76K 54,596 at 7.89
11.0%
Not planned
MDXG MIMEDX GROUP, INC.
13 Mar 2025
Maersk-Moller Kimberly Chief Commercial Officer
Sold at will
$32.40K 4,106 at 7.89
1.3%
Not planned
MDXG MIMEDX GROUP, INC.
10 Mar 2025
Hulse William Frank IV General Counsel and CAO
Sold at will
$635.28K 81,446 at 7.80
14.1%
Not planned
MDXG MIMEDX GROUP, INC.
28 Feb 2025
Maersk-Moller Kimberly Chief Commercial Officer
Sold at will
$17.74K 2,111 at 8.41
0.8%
Not planned
MDXG MIMEDX GROUP, INC.
13 Feb 2025
Whitlow Ricci S Chief Operating Officer
Sold at will
$508.56K 61,420 at 8.28
13.2%
Not planned
MDXG MIMEDX GROUP, INC.
13 Mar 2024
Hulse William Frank IV General Counsel and CAO
Sold at will
$162.03K 20,381 at 7.95
4.1%
Not planned
MDXG MIMEDX GROUP, INC.
20 Feb 2024
Whitlow Ricci S Chief Operating Officer
Sold at will
$122.35K 15,271 at 8.01
3.7%
Not planned
MDXG MIMEDX GROUP, INC.
16 Feb 2024
Whitlow Ricci S Chief Operating Officer
Sold at will
$125.07K 15,493 at 8.07
3.6%
Not planned
MDXG MIMEDX GROUP, INC.
15 Feb 2024
Whitlow Ricci S Chief Operating Officer
Sold at will
$122.50K 15,198 at 8.06
3.4%
Not planned
MDXG MIMEDX GROUP, INC.
14 Feb 2024
Whitlow Ricci S Chief Operating Officer
Sold at will
$127.27K 15,845 at 8.03
3.4%
Not planned
MDXG MIMEDX GROUP, INC.
16 May 2023
Stein Robert Benjamin President, Regenerative Med.
Sold at will
$61.63K 10,365 at 5.95
3.2%
Not planned
MDXG MIMEDX GROUP, INC.
15 May 2023
Stein Robert Benjamin President, Regenerative Med.
Sold at will
$22.17K 3,607 at 6.15
1.1%
Not planned
MDXG MIMEDX GROUP, INC.
10 May 2023
Carlson Peter M Chief Financial Officer
Sold at will
$35.41K 5,976 at 5.93
0.9%
Not planned
MDXG MIMEDX GROUP, INC.
10 May 2023
Hulse William Frank IV General Counsel and CAO
Sold at will
$34.79K 5,870 at 5.93
1.3%
Not planned
MDXG MIMEDX GROUP, INC.
10 May 2023
Stein Robert Benjamin President, Regenerative Med.
Sold at will
$34.78K 5,869 at 5.93
1.7%
Not planned
MDXG MIMEDX GROUP, INC.
10 May 2023
Phelan William Lawrence Chief Accounting Officer
Sold at will
$9.45K 1,595 at 5.93
0.9%
Not planned
MDXG MIMEDX GROUP, INC.
4 May 2023
Stein Robert Benjamin President, Regenerative Med.
Sold at will
$276.47K 51,756 at 5.34
13.3%
Not planned
MDXG MIMEDX GROUP, INC.
2 May 2023
Phelan William Lawrence Chief Accounting Officer
Sold at will
$19.74K 5,200 at 3.80
2.7%
Not planned
MDXG MIMEDX GROUP, INC.
25 Apr 2023
Carlson Peter M Chief Financial Officer
Sold at will
$22.82K 6,094 at 3.74
0.9%
Not planned
MDXG MIMEDX GROUP, INC.
25 Apr 2023
Hulse William Frank IV General Counsel and CAO
Sold at will
$22.42K 5,988 at 3.74
1.3%
Not planned
MDXG MIMEDX GROUP, INC.
25 Apr 2023
Stein Robert Benjamin President, Regenerative Med.
Sold at will
$22.42K 5,987 at 3.74
1.5%
Not planned
MDXG MIMEDX GROUP, INC.
25 Apr 2023
Phelan William Lawrence Chief Accounting Officer
Sold at will
$6.10K 1,628 at 3.74
0.8%
Not planned
MDXG MIMEDX GROUP, INC.
11 Apr 2023
Carlson Peter M Chief Financial Officer
Sold at will
$20.19K 6,100 at 3.31
0.9%
Not planned
MDXG MIMEDX GROUP, INC.
11 Apr 2023
Stein Robert Benjamin President, Regenerative Med.
Sold at will
$19.85K 5,996 at 3.31
1.5%
Not planned
MDXG MIMEDX GROUP, INC.
11 Apr 2023
Hulse William Frank IV General Counsel and CAO
Sold at will
$19.84K 5,995 at 3.31
1.3%
Not planned
MDXG MIMEDX GROUP, INC.
11 Apr 2023
Phelan William Lawrence Chief Accounting Officer
Sold at will
$5.40K 1,632 at 3.31
0.8%
Not planned
MDXG MIMEDX GROUP, INC.
7 Mar 2023
Stein Robert Benjamin President, Regenerative Med.
Sold, plan not stated
$52.44K 12,355 at 4.24
4.4%
MDXG MIMEDX GROUP, INC.
7 Mar 2023
Carlson Peter M Chief Financial Officer
Sold, plan not stated
$51.17K 12,056 at 4.24
2.2%
MDXG MIMEDX GROUP, INC.
7 Mar 2023
Hulse William Frank IV General Counsel and CAO
Sold, plan not stated
$48.00K 11,308 at 4.24
3.2%
MDXG MIMEDX GROUP, INC.
7 Mar 2023
Phelan William Lawrence Chief Accounting Officer
Sold, plan not stated
$14.41K 3,396 at 4.24
2.3%
MDXG MIMEDX GROUP, INC.
23 Feb 2023
Carlson Peter M Chief Financial Officer
Sold, plan not stated
$85.42K 19,000 at 4.50
3.4%
MDXG MIMEDX GROUP, INC.
23 Feb 2023
Hulse William Frank IV General Counsel and CAO
Sold, plan not stated
$70.48K 15,555 at 4.53
4.3%
MDXG MIMEDX GROUP, INC.
22 Dec 2022
Carlson Peter M Chief Financial Officer
Sold, plan not stated
$14.05K 4,992 at 2.82
0.9%
MDXG MIMEDX GROUP, INC.
13 Sep 2022
Stein Robert Benjamin President, Regenerative Med.
Sold, plan not stated
$28.79K 8,329 at 3.46
2.9%
MDXG MIMEDX GROUP, INC.
12 Sep 2022
Stein Robert Benjamin President, Regenerative Med.
Sold, plan not stated
$65.28K 19,000 at 3.44
6.2%
MDXG MIMEDX GROUP, INC.
12 Aug 2022
Stein Robert Benjamin President, Regenerative Med.
Sold, plan not stated
$34.34K 8,503 at 4.04
2.7%
MDXG MIMEDX GROUP, INC.
9 Aug 2022
Kashyap Rohit President, WC & Surgical
Sold, plan not stated
$51.94K 12,343 at 4.21
2.8%
MDXG MIMEDX GROUP, INC.
4 Aug 2022
Stein Robert Benjamin President, Regenerative Med.
Sold, plan not stated
$70.59K 19,500 at 3.62
5.8%
MDXG MIMEDX GROUP, INC.
28 Jun 2022
Stein Robert Benjamin President, Regenerative Med.
Sold, plan not stated
$50.66K 14,600 at 3.47
4.2%
MDXG MIMEDX GROUP, INC.
9 Jun 2022
WRIGHT TIMOTHY R Chief Executive Officer
Sold, plan not stated
$420.00K 112,000 at 3.75
6.1%
MDXG MIMEDX GROUP, INC.
9 May 2022
Graves Mark SVP & Chief Compliance Officer
Sold, plan not stated
$13.62K 3,891 at 3.50
2.8%
MDXG MIMEDX GROUP, INC.
6 May 2022
Phelan William Lawrence Chief Accounting Officer
Sold, plan not stated
$21.91K 5,750 at 3.81
3.8%
MDXG MIMEDX GROUP, INC.
2 May 2022
Turner Scott M SVP, Operations & Procurement
Sold, plan not stated
$21.05K 5,260 at 4.00
2.3%
MDXG MIMEDX GROUP, INC.
8 Mar 2022
WRIGHT TIMOTHY R Chief Executive Officer
Sold, plan not stated
$221.62K 45,611 at 4.86
3.6%
MDXG MIMEDX GROUP, INC.
8 Mar 2022
Stein Robert Benjamin EVP, Research and Development
Sold, plan not stated
$56.71K 11,672 at 4.86
6.4%
MDXG MIMEDX GROUP, INC.
8 Mar 2022
Carlson Peter M Chief Financial Officer
Sold, plan not stated
$52.20K 10,743 at 4.86
2.7%
MDXG MIMEDX GROUP, INC.
8 Mar 2022
Hulse William Frank IV General Counsel
Sold, plan not stated
$48.54K 9,990 at 4.86
5.1%
MDXG MIMEDX GROUP, INC.
8 Mar 2022
Kashyap Rohit EVP & Chief Commercial Officer
Sold, plan not stated
$42.61K 8,770 at 4.86
3.2%
Showing 1–50 of 67. Page 1 of 2 Older →